Phase I/II trial of gefitinib and RAD001 (everolimus) in patients (pts) with advanced non-small cell lung cancer (NSCLC) Meeting Abstract


Authors: Milton, D. T.; Kris, M. G.; Azzoli, C. G.; Gomez, J. E.; Heelan, R.; Krug, L. M.; Pao, W.; Pizzo, B.; Rizvi, N. A.; Miller, V. A.
Abstract Title: Phase I/II trial of gefitinib and RAD001 (everolimus) in patients (pts) with advanced non-small cell lung cancer (NSCLC)
Meeting Title: 41st Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 23
Issue: 16 Suppl.
Meeting Dates: 2005 May 13-17
Meeting Location: Orlando, FL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2005-06-01
Start Page: 646S
Language: English
ACCESSION: WOS:000230326604220
PROVIDER: wos
DOI: 10.1200/jco.2005.23.16_suppl.7014
Notes: --- - Meeting Abstract: 7104 - 41st Annual Meeting of the American-Society-of-Clinical-Oncology - MAY 13-17, 2005 - Orlando, FL - S - Part 1 - "Source: Wos"
Altmetric
Citation Impact
MSK Authors
  1. Jorge Gomez
    27 Gomez
  2. Daniel T Milton
    14 Milton
  3. Lee M Krug
    221 Krug
  4. Christopher G Azzoli
    111 Azzoli
  5. William Pao
    141 Pao
  6. Naiyer A Rizvi
    166 Rizvi
  7. Vincent Miller
    270 Miller
  8. Mark Kris
    847 Kris
  9. Robert T Heelan
    140 Heelan
  10. Barbara Pizzo
    31 Pizzo